On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayAug 30, 2012 11:07 am

Selectica, Inc. (SLTC) Guided Selling Recognized as a Finalist in the Best New SaaS or Cloud Computing Product Category

Selectica, a provider of software that improves sales cycles and streamlines contract processes, has been acknowledged as a finalist in the 4th Annual 2012 Golden Bridge Awards for the Best New SaaS or Cloud Computing category for its Selectica Guided Selling cloud-based offering. "Selectica Guided Selling empowers growing companies and their sales channels to accurately map customer needs to their solutions, and protect margins by enforcing pricing and approval policies," said Kamal Ahluwalia, Chief Strategy Officer at Selectica. "We're honored to have the Golden Bridge Awards acknowledge our mission to deliver this patented, cloud-based sales technology to a broader market."…

Continue Reading

ThursdayAug 30, 2012 9:18 am

International Stem Cell Corp. (ISCO) Reports Investor Conference Schedule for September

International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, today told investors of the conferences it will be presenting at next month. Wall Street Analyst Forum Investor Conference Date: Friday, September 7, 2012 Time: 10:35 am ET Location: Omni Parker House - Boston, MA Rodman & Renshaw Annual Global Investment Conference Date: Monday, September 10, 2012 Time: 11:40 am ET Location: The Waldorf Astoria Hotel, New York, NY Investors interested in attending these conferences should contact the event organizers.…

Continue Reading

ThursdayAug 30, 2012 8:28 am

AcelRx Pharmaceuticals, Inc. (ACRX) Receives U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms

AcelRx Pharmaceuticals announced that patents have been approved for “Bioadhesive Drug Formulations for Oral Transmucosal Delivery," and "Bioadhesive Drug Formulations for Oral Transmucosal Delivery." The issued patents will provide intellectual property protection for a bioadhesive tablet for oral transmucosal administration of sufentanil through January 2027. AcelRx exclusively owns both patents. "We have made significant progress this year in establishing our intellectual property portfolio, with five issued US patents now underpinning our novel NanoTab technology," said Richard King, AcelRx's President and CEO. "We look forward to building on this success through emphasis on the device aspects of our technology platforms as…

Continue Reading

ThursdayAug 30, 2012 8:22 am

Stevia First Corp. (STVF) Licenses Fermentation-based Intellectual Property from Vineland Research and Innovation Centre

Stevia First is an early-stage agribusiness focused on the industrial scale production of the natural sweetener stevia, which is used as a zero-calorie alternative to sugar in foods and beverages. The California-based company today announced that it has entered into an exclusive and worldwide intellectual property license with the Vineland Research and Innovation Centre of Ontario, Canada, regarding compositions and methods for producing steviol and steviol glycosides through fermentation-based production methods. Stevia First also said it has inked a separate consulting agreement with Vineland to assist with further development of the underlying intellectual property. The production of stevia extract involves…

Continue Reading

WednesdayAug 29, 2012 4:33 pm

Teletouch Communications, Inc. (TLLE) Reports Financial Results and Operational Highlights for Fiscal Year 2012

Teletouch Communications, a leading U.S. cellular services provider and consumer electronics distributor supporting over 60,000 wireless customers, earlier today reported its audited consolidated results on Form 10-K for the 2012 fiscal year ended May 31, 2012. Financial highlights of the year include total operating revenues of $34.42 million; income from operations of $6.32 million; EBITDA of $7.48 million; net income of $4.17 million; basic earnings per share of $0.09; diluted earnings per share of $0.08; and reduction of total liabilities by $6.59 million. For the fourth quarter alone, the company reported total operating revenues of $8.30 million; income from operations…

Continue Reading

WednesdayAug 29, 2012 2:51 pm

Santa Fe Gold Corp. (SFEG) Raises $2.3M via S-3 Offerings with Strong Sales/Output, Ramps Up Flagship Gold and Silver Project

Santa Fe Gold, the domestic precious metals-focused mineral developer with four advanced properties in mining-friendly districts, the flagship of which started running ore in April this year at a cost of only $364 per gold equivalent ounce, was pleased to announce today that the company pulled in some $2.3M from S-3 shelf registration statement-related offerings, largely from existing stockholders. Combined with the money coming in from the sale of gold and silver, this great news about the success of the offerings puts SFEG in a prime position to capitalize on the expansion potential at their flagship Summit silver-gold project. Recent…

Continue Reading

WednesdayAug 29, 2012 2:47 pm

Trovagene, Inc. (TROV) Receives Milestone Payment from Ipsogen S.A.

Trovagene is developing its patented technology for the detection of transrenal DNA and RNA, short nucleic acid fragments, originating from normal and diseased cell deaths that cross the kidney barrier and can be detected in urine. The company is leveraging its intellectual property through out-licensing agreements. The company today announced that it has received a milestone payment from Ipsogen S.A., a subsidiary of Qiagen N.V. (Nasdaq: QGEN). This payment comes from a co-exclusive license agreement to manufacture and sell diagnostic kits for the detection of nucleophosmin protein (NPM1) mutations in patients with acute myeloid leukemia (AML). The payment was triggered…

Continue Reading

WednesdayAug 29, 2012 10:45 am

Liberty Silver Corp. (LBSV) Video Chart for Wednesday, August 29, 2012

LBSV closed ahead yesterday on a substantial increase in volume. The chart has been building higher lows since apparently finding a bottom in May around 50 cents. As the indicators are turning bullish, the chart is worthy of a technical read for signs of potentially more upward pressure. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

Continue Reading

WednesdayAug 29, 2012 10:11 am

Axcelis Technologies, Inc. (ACLS) Announces High Volume Follow-On Order from Major Chipmaker

Axcelis Technologies, a leader in supplying innovative, high-productivity solutions for the semiconductor industry, has announced its receipt of a multiple system follow-on order for its Integra RS plasma dry strip system from one of the leading semiconductor manufacturers in the world. The systems, which began shipping this month, will be utilized in the production of 3x nm and below NAND Flash devices at leading-edge fabs in Asia and the United States. Axcelis is pleased to expand its installed base in working with this industry leader and supporting its evolving manufacturing needs. The Integra dry strip system has shown superior manufacturing…

Continue Reading

WednesdayAug 29, 2012 9:05 am

China Botanic Pharmaceutical, Inc. (CBP) to be Granted New Invention Patent in China

China Botanic Pharmaceutical recently announced that the State Intellectual Property Office of the People’s Republic of China (SIPO) will be granting the company a new invention patent on its comprehensive method to enhance the medicinal value of Schisandra, a key component in its pharmaceutical products. The company expects to receive the patent certificate by October 2012. China Botanic filed Patent Application No: 201010119861.3 in February 2010, which was followed by a two-year comprehensive review conducted by the SIPO. Upon grant of the new patent, the company anticipates securing market exclusivity for a period of 20 years. Research in China suggests…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered